Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool

DETROIT, Nov. 16 /PRNewswire-USNewswire/ -- After more than 10 years of research and development, the Barbara Ann Karmanos Cancer Institute announced its launch of a new company to build and market a breast cancer screening device invented at Karmanos. The innovative technology developed as C.U.R.E. (Computerized Ultrasound Risk Evaluation), now referred to as SoftVue, will be marketed under the new spin-off company called Delphinus Medical Technologies, LLC. The company has already secured sale commitments for the SoftVue system from several health institutions nationally and internationally.

More than 300 women were involved in the initial clinical studies, which confirmed that SoftVue accurately and safely identifies breast cancer. SoftVue uses multi-parametric ultrasound and sophisticated computer algorithms rather than X-rays. The SoftVue exam takes about one minute, does not involve radiation or compression as the current mammography, and is a fraction of the cost of MRI (magnetic resonance imaging). It's believed that it will help reduce the number of false positives that can occur with mammography and thereby reduce unnecessary biopsies.

source: PR Newswire